Biotech Bubble has Burst-Back to Basics: ABBV, HOLX
Risk-Off -Stay With Large Caps In case you missed it the speculative frenzy in biotech stocks is over for now but there are always trading opportunities for the short and long term. We recently posted our Q1 Rayno Life Science update for biopharmaceuticals and the large cap stocks are holding...
Rayno Biopharmaceutical Stocks: April 2014 Update After Sell-Off… Update 10/6/14
Note: Prices are updated as of 10/6/14 Stocks on the list that are lower from 5/2 are: ALKS, ARIA,CBST, IMGN (dropped)-all others are up. Biotech Stocks Are Down 5-10% in April-IBB is up only 1% YTD but 32% over one year May 2 Mid-day trading: NASDAQ 41358 up 0.25%, FBT 74.10IBB $229.4, XBI...
Large Cap Biopharmaceuticals 2014 Q2 Metrics: ALXN, AMGN, BIIB.. Update
Update August 5, 2014 Large Cap Biopharmaceutical Stocks Includes Q1 Earnings Reports (except REGN due 5/8) Rayno Focus Picks: ALXN, AMGN, BIIB, FBT, GILD, REGN, RHHBY Large cap stocks are core holdings especially now that sector momentum is easing. ABBV dropped due to inversion play and...
Rayno DX and Tools: Trading Pick of the Day Trinity Biotech (TRIB)
Trinity Biotech (TRIB $24.90), a Buy Around $25 Barrons published an article over the weekend recommending Trinity Biotech plc, an Irish diagnostic Company focused in point of care (POC) and clinical laboratory diagnostic tests. We agree with the article and will provide a follow-up review this...
Biotech Sell-Off Resumes-Another Test For April 15 Bottom.. Update-2.. 4/29
Biotech Sector Perking Up in Active Trading 2:15 P Tuesday Key tracking indices: NASDAQ 4107 up 0.83%, IBB 229.2 up 2.75%, XBI 128.40 up 3.9%, XLV $58 up 0.55%. Rayno Biopharma Portfolio Movers Up: ABBV, ALKS, ALXN,BIIB, CBST, GILD, PCYC, SGEN etc Rayno Dx and Tools Portfolio Movers Up:...